CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 15 enrolled
Drug / intervention
Corticosteroid +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00769184
NCT00769184N/ACompleted
CompareCT.gov

A Steroid-Sparing Effect of Supplemental LCD Treatment in Patients With Moderate-to-Severe Localized Psoriasis Lesions: a Pilot Study.

NeoStrata Company, Inc.·interventional·Posted Oct 9, 2008·Updated Aug 19, 2015

In Brief

A clinical study evaluating Corticosteroid, Placebo, and 1 other intervention for Psoriasis. Completed, enrolled 15 participants across 1 site.

Detailed Summary

This is a 12 week bilateral study, consisting of 6 weeks of treatment and 6 weeks of follow-up. The purpose of the study is to compare the safety and effectiveness of combining and then following a high potency topical corticosteroid treatment with LCD treatment for moderate-to-severe localized plaque psoriasis.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPsoriasis
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedOct 9, 2008
Enrollment StartOct 1, 2008
Primary CompletionApr 1, 2009
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 17.7 years ago

Interventions

Corticosteroiddrug

One side of body: clobetasol: 2 applications / day along with LCD application 2 applications/day

Placeboother

One side of body: Placebo Solution: 2 applications / day along with clobetasol 2 applications/day

LCDdrug

One side of body: LCD Solution: 2 applications / day along with clobetasol 2 applications/day